Literature DB >> 16360137

Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.

Steven J Soldin1, Offie P Soldin, Alanna J Boyajian, Madeline S Taskier.   

Abstract

BACKGROUND: Brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) have been shown to be useful biomarkers for the diagnosis of heart failure. Pediatric reference intervals for these analytes have been reported in part. Previous studies lack large numbers in each group, have not covered all age ranges and have not compared results for BNP with NT-proBNP in simultaneously drawn samples.
METHODS: We measured BNP in whole blood using the Biosite Triage point-of-care method and plasma NT-proBNP using the Dade RxL Dimension. We assessed between and within-day precision of both methods and after removing outliers employed the Hoffmann approach to calculate pediatric reference intervals over the age range of 0-21 y. We also compared the 2 methods on simultaneously drawn samples.
RESULTS: Reference intervals revealed approximately 20-fold higher 97.5th percentiles for neonates than for children >3 y of age. 97.5th percentiles decreased significantly over the first 3 years of life. As shown by others, the CVs for the automated Dade RxL platform were somewhat lower than those for the POCT method. BNP and NT-proBNP correlated well in simultaneously drawn samples (r=0.947). DISCUSSION: Reference intervals for BNP and NT-proBNP are far higher in neonates and infants than in children older than three years of age. The reasons for this are unknown but resemble the elevated CK-MBs and troponins also found in neonates, although the 97.5th percentiles for these latter 2 cardiac markers decrease more rapidly to values found in older children by 6 months of age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360137      PMCID: PMC3636975          DOI: 10.1016/j.cca.2005.11.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  25 in total

1.  STATISTICS IN THE PRACTICE OF MEDICINE.

Authors:  R G HOFFMANN
Journal:  JAMA       Date:  1963-09-14       Impact factor: 56.272

2.  Laboratory and clinical aspects of B-type natriuretic peptides.

Authors:  Ronald J Elin; William E Winter
Journal:  Arch Pathol Lab Med       Date:  2004-06       Impact factor: 5.534

3.  Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays.

Authors:  O P Soldin; L Hilakivi-Clarke; E Weiderpass; S J Soldin
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

4.  Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood.

Authors:  Jaap Bakker; Inge Gies; Barbara Slavenburg; Otto Bekers; Tammo Delhaas; Marja van Dieijen-Visser
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

5.  N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers.

Authors:  Angelika Hammerer-Lercher; Johannes Mair; Gernot Tews; Bernd Puschendorf; Rudolf Sommer
Journal:  Clin Chem       Date:  2005-05       Impact factor: 8.327

6.  Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency.

Authors:  O P Soldin; R E Tractenberg; J G Hollowell; J Jonklaas; N Janicic; S J Soldin
Journal:  Thyroid       Date:  2004-12       Impact factor: 6.568

7.  Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin.

Authors:  S J Soldin; A Morales; F Albalos; S Lenherr; N Rifai
Journal:  Clin Biochem       Date:  1995-12       Impact factor: 3.281

8.  Pediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000.

Authors:  Offie P Soldin; Eve G Hoffman; Michael A Waring; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

9.  Pediatric reference ranges for creatine kinase, CKMB, Troponin I, iron, and cortisol.

Authors:  S J Soldin; J N Murthy; P K Agarwalla; O Ojeifo; J Chea
Journal:  Clin Biochem       Date:  1999-02       Impact factor: 3.281

10.  Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth.

Authors:  M Yoshibayashi; T Kamiya; Y Saito; K Nakao; K Nishioka; S Temma; H Itoh; G Shirakami; H Matsuo
Journal:  Eur J Endocrinol       Date:  1995-08       Impact factor: 6.664

View more
  21 in total

1.  Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise.

Authors:  Tamara Hew-Butler; Esme Jordaan; Kristin J Stuempfle; Dale B Speedy; Arthur J Siegel; Timothy D Noakes; Steven J Soldin; Joseph G Verbalis
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

2.  Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist?

Authors:  T Hew-Butler; T D Noakes; S J Soldin; J G Verbalis
Journal:  Br J Sports Med       Date:  2008-09-18       Impact factor: 13.800

3.  N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.

Authors:  Hyuksool Kwon; Jin Hee Lee; Jae Yun Jung; Young Ho Kwak; Do Kyun Kim; Jin Hee Jung; Ikwan Chang; Kyuseok Kim
Journal:  Eur J Pediatr       Date:  2016-10-31       Impact factor: 3.183

Review 4.  N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.

Authors:  Eva Welisch; Kambiz Norozi; Ralf Rauch
Journal:  Clin Res Cardiol       Date:  2011-04-14       Impact factor: 5.460

5.  NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study.

Authors:  Annalisa Paolino; Tarique Hussain; Antonio Pavon; Maria Nieves Velasco; Sergio Uribe; Antonio Ordoñez; Israel Valverde
Journal:  Pediatr Cardiol       Date:  2016-11-21       Impact factor: 1.655

6.  Aminoterminal Pro B-Type Natriuretic Peptide (NT-proBNP) Levels for Monitoring Interventions in Paediatric Cardiac Patients with Stenotic Lesions.

Authors:  Eva Welisch; Knut Kleesiek; Nikolaus Haas; Kambiz Norozi; Ralf Rauch; Guido Filler
Journal:  Int J Pediatr       Date:  2010-02-24

7.  IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone.

Authors:  Offie P Soldin; Julia R B Dahlin; Eric G Gresham; Julia King; Steven J Soldin
Journal:  Clin Biochem       Date:  2008-05-15       Impact factor: 3.281

Review 8.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 9.  Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

Authors:  Afif El-Khuffash; Eleanor J Molloy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

10.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.